Your browser doesn't support javascript.
loading
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.
Versteijne, Eva; van Dam, Jacob L; Suker, Mustafa; Janssen, Quisette P; Groothuis, Karin; Akkermans-Vogelaar, Janine M; Besselink, Marc G; Bonsing, Bert A; Buijsen, Jeroen; Busch, Olivier R; Creemers, Geert-Jan M; van Dam, Ronald M; Eskens, Ferry A L M; Festen, Sebastiaan; de Groot, Jan Willem B; Groot Koerkamp, Bas; de Hingh, Ignace H; Homs, Marjolein Y V; van Hooft, Jeanin E; Kerver, Emile D; Luelmo, Saskia A C; Neelis, Karen J; Nuyttens, Joost; Paardekooper, Gabriel M R M; Patijn, Gijs A; van der Sangen, Maurice J C; de Vos-Geelen, Judith; Wilmink, Johanna W; Zwinderman, Aeilko H; Punt, Cornelis J; van Tienhoven, Geertjan; van Eijck, Casper H J.
Afiliação
  • Versteijne E; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • van Dam JL; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Suker M; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Janssen QP; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Groothuis K; Clinical Research Department, Comprehensive Cancer Organisation the Netherlands (IKNL) Nijmegen, the Netherlands.
  • Akkermans-Vogelaar JM; Clinical Research Department, Comprehensive Cancer Organisation the Netherlands (IKNL) Nijmegen, the Netherlands.
  • Besselink MG; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Bonsing BA; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • Buijsen J; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Busch OR; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Creemers GM; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.
  • van Dam RM; Department of Surgery, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Eskens FALM; Department of General, Visceral and Transplant Surgery, University Hospital Aachen, Aachen, Germany.
  • Festen S; GROW - School for Oncology and Developmental Biology, Maastricht University, the Netherlands.
  • de Groot JWB; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Groot Koerkamp B; Department of Surgery, OLVG, Amsterdam, the Netherlands.
  • de Hingh IH; Department of Medical Oncology, Isala Oncology Center, Zwolle, the Netherlands.
  • Homs MYV; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • van Hooft JE; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.
  • Kerver ED; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Luelmo SAC; Department of Gastroenterology and Hepatology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Neelis KJ; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Nuyttens J; Department of Medical Oncology, OLVG, Amsterdam, the Netherlands.
  • Paardekooper GMRM; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Patijn GA; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • van der Sangen MJC; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • de Vos-Geelen J; Department of Radiation Oncology, Isala Oncology Center, Zwolle, the Netherlands.
  • Wilmink JW; Department of Surgery, Isala Oncology Center, Zwolle, the Netherlands.
  • Zwinderman AH; Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands.
  • Punt CJ; Department of Internal Medicine, Division of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht UMC+, Maastricht, the Netherlands.
  • van Tienhoven G; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • van Eijck CHJ; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
J Clin Oncol ; 40(11): 1220-1230, 2022 04 10.
Article em En | MEDLINE | ID: mdl-35084987
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Terapia Neoadjuvante Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Terapia Neoadjuvante Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article